Transformative Biotech Selected to Present at 2026 Rocky Mountain Life Sciences Investor & Partnering Conference
PCR is the gold standard for diagnosing infectious diseases, but its complexity has kept it confined to...
Transformative Biotech Featured in GenomeWeb
Transformative Biotech was featured in GenomeWeb on April 17, 2026, in an article highlighting the company's DirectAmp™...
Transformative Biotech Names Mark Kelleher, PhD as Executive VP of R&D
Industry veteran to drive assay and system development for extraction-free PCR Boulder, Colo., February 26, 2026 – Transformative...
Transformative Biotech Appoints Industry Veteran Kevin Kraus as CEO
Kraus to lead commercialization of the company’s patented extraction-free technologies. Boulder, Colo., December 10, 2025 – Transformative Biotech...
Extraction-Free Testing for SARS-CoV-2 in Nasal Swab and Saliva Samples on a Single High-Throughput Platform
Yue Qiu, Ling Lu, Amanda Halven, Rachel Terrio, Sydney Yuldelson, Natalie Dougal, Filippo Galbo, Andrew Lu, Dexiang...
Transformative Biotech Welcomes Dr. Barbara Handelin
Veteran entrepreneur and molecular medical geneticist appointed as Transformative Biotech's Co-CEO and Director BOULDER, Colo., May 15, 2024...
Transformative Biotech Acquires Summit Biolabs’ Direct-to-PCR Technologies
NEW YORK – Boulder, Colorado-based Transformative Biotech announced on Thursday that it has acquired extraction-free, direct-to-PCR technologies...
Transformative Biotech Purchases Direct-to-PCR Technologies From Summit Biolabs
Market-proven technologies in this intellectual property transaction offers many advantages over traditional PCR testing. BOULDER, Colo., May 18,...
Formation of Transformative Biotech, LLC
Transformative Biotech created to deploy direct-to-PCR technologies in the fields of molecular diagnostics of infectious diseases and...
